Discounted Cash Flow (DCF) Analysis Levered
Amedisys, Inc. (AMED)
$77.31
+0.56 (+0.73%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Revenue | 1,662.58 | 1,955.63 | 2,071.52 | 2,214.11 | 2,223.20 | 2,394.64 | 2,579.31 | 2,778.21 | 2,992.45 | 3,223.22 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue (%) | ||||||||||
Operating Cash Flow | 223.48 | 202 | 288.95 | 188.89 | 133.28 | 250.22 | 269.52 | 290.30 | 312.69 | 336.80 |
Operating Cash Flow (%) | ||||||||||
Capital Expenditure | -6.56 | -7.89 | -5.33 | -6.30 | -6.16 | -7.74 | -8.34 | -8.99 | -9.68 | -10.42 |
Capital Expenditure (%) | ||||||||||
Free Cash Flow | 216.92 | 194.11 | 283.62 | 182.59 | 127.12 | 242.48 | 261.18 | 281.32 | 303.01 | 326.38 |
Weighted Average Cost Of Capital
Share price | $ 77.31 |
---|---|
Beta | 1.016 |
Diluted Shares Outstanding | 33.27 |
Cost of Debt | |
Tax Rate | 25.98 |
After-tax Cost of Debt | 3.03% |
Risk-Free Rate | |
Market Risk Premium | |
Cost of Equity | 8.606 |
Total Debt | 542.75 |
Total Equity | 2,571.95 |
Total Capital | 3,114.70 |
Debt Weighting | 17.43 |
Equity Weighting | 82.57 |
Wacc |
Build Up Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Revenue | 1,662.58 | 1,955.63 | 2,071.52 | 2,214.11 | 2,223.20 | 2,394.64 | 2,579.31 | 2,778.21 | 2,992.45 | 3,223.22 |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | 223.48 | 202 | 288.95 | 188.89 | 133.28 | 250.22 | 269.52 | 290.30 | 312.69 | 336.80 |
Capital Expenditure | -6.56 | -7.89 | -5.33 | -6.30 | -6.16 | -7.74 | -8.34 | -8.99 | -9.68 | -10.42 |
Free Cash Flow | 216.92 | 194.11 | 283.62 | 182.59 | 127.12 | 242.48 | 261.18 | 281.32 | 303.01 | 326.38 |
WACC | ||||||||||
PV LFCF | 225.27 | 225.42 | 225.57 | 225.72 | 225.87 | |||||
SUM PV LFCF | 1,127.83 |
Terminal Value
Growth in perpetuity method: | |
---|---|
Long-term growth rate | |
WACC (%) | 7.64 |
Free cash flow (t + 1) | 332.91 |
Terminal Value | 5,902.58 |
Present Value of Terminal Value | 4,084.82 |
Intrinsic Value
Enterprise Value | 5,212.66 |
---|---|
Net Debt | 502.21 |
Equity Value | 4,710.45 |
Shares Outstanding | 33.27 |
Equity Value Per Share | 141.59 |